Qiagen N.V [QGEN] vs Guardant Health [GH] Detailed Stock Comparison
Qiagen N.V
NYSE
Loading...
Guardant Health
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Qiagen N.V wins in 11 metrics, Guardant Health wins in 7 metrics, with 0 ties. Qiagen N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Qiagen N.V | Guardant Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.03 | -17.45 | Guardant Health |
| Price-to-Book Ratio | 2.72 | -25.24 | Guardant Health |
| Debt-to-Equity Ratio | 42.31 | -4.37 | Guardant Health |
| PEG Ratio | -0.17 | 3.66 | Qiagen N.V |
| EV/EBITDA | 10.08 | -20.38 | Guardant Health |
| Profit Margin (TTM) | 18.30% | -49.93% | Qiagen N.V |
| Operating Margin (TTM) | 25.49% | -45.75% | Qiagen N.V |
| EBITDA Margin (TTM) | 25.49% | N/A | N/A |
| Return on Equity | 10.81% | 312.48% | Guardant Health |
| Return on Assets (TTM) | 9.01% | -19.57% | Qiagen N.V |
| Free Cash Flow (TTM) | $502.31M | $-274.94M | Qiagen N.V |
| 1-Year Return | 6.13% | 177.35% | Guardant Health |
| Price-to-Sales Ratio (TTM) | 4.68 | 9.33 | Qiagen N.V |
| Enterprise Value | $10.06B | $8.54B | Qiagen N.V |
| EV/Revenue Ratio | 4.93 | 10.31 | Qiagen N.V |
| Gross Profit Margin (TTM) | 62.65% | 65.01% | Guardant Health |
| Revenue per Share (TTM) | $9 | $7 | Qiagen N.V |
| Earnings per Share (Diluted) | $1.69 | $-3.46 | Qiagen N.V |
| Beta (Stock Volatility) | 0.64 | 1.46 | Qiagen N.V |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Qiagen N.V vs Guardant Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Qiagen N.V | -0.17% | 5.26% | -1.45% | -4.93% | 15.54% | 3.86% |
| Guardant Health | -1.90% | 2.13% | -7.59% | 22.48% | 41.32% | 93.45% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Qiagen N.V | 6.13% | 8.77% | -15.53% | 71.77% | 159.63% | 235.07% |
| Guardant Health | 177.35% | 10.24% | -43.19% | 110.48% | 110.48% | 110.48% |
News Based Sentiment: Qiagen N.V vs Guardant Health
Qiagen N.V
News based Sentiment: POSITIVE
Qiagen demonstrated resilience in a down market, secured a key partnership expansion in Japan, received an analyst upgrade, and benefits from a strong growth forecast in the cancer biomarkers market. These factors collectively suggest a positive outlook for the company, though valuation remains fair.
Guardant Health
News based Sentiment: POSITIVE
Guardant Health delivered a strong Q2 performance with revenue exceeding expectations and raised full-year guidance. A significant legal victory and key partnerships further bolster the company's position, though continued cash burn remains a concern. These developments suggest a positive trajectory for the company, making October a significant month for investors.
Performance & Financial Health Analysis: Qiagen N.V vs Guardant Health
| Metric | QGEN | GH |
|---|---|---|
| Market Information | ||
| Market Cap | $9.69B | $7.73B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,123,284 | 2,782,030 |
| 90 Day Avg. Volume | 1,273,311 | 2,486,587 |
| Last Close | $46.24 | $61.46 |
| 52 Week Range | $37.63 - $51.88 | $20.14 - $68.00 |
| % from 52W High | -10.87% | -9.62% |
| All-Time High | $60.81 (Jul 17, 2000) | $181.07 (Feb 08, 2021) |
| % from All-Time High | -23.96% | -66.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.31% |
| Quarterly Earnings Growth | 0.07% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | -0.50% |
| Operating Margin (TTM) | 0.25% | -0.46% |
| Return on Equity (TTM) | 0.11% | 3.12% |
| Debt to Equity (MRQ) | 42.31 | -4.37 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.17 | $-2.45 |
| Cash per Share (MRQ) | $4.40 | $4.19 |
| Operating Cash Flow (TTM) | $675.03M | $-238,546,000 |
| Levered Free Cash Flow (TTM) | $683.15M | $-131,174,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Qiagen N.V vs Guardant Health
| Metric | QGEN | GH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.03 | -17.45 |
| Forward P/E | 19.21 | -22.87 |
| PEG Ratio | -0.17 | 3.66 |
| Price to Sales (TTM) | 4.68 | 9.33 |
| Price to Book (MRQ) | 2.72 | -25.24 |
| Market Capitalization | ||
| Market Capitalization | $9.69B | $7.73B |
| Enterprise Value | $10.06B | $8.54B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.93 | 10.31 |
| Enterprise to EBITDA | 10.08 | -20.38 |
| Risk & Other Metrics | ||
| Beta | 0.64 | 1.46 |
| Book Value per Share (MRQ) | $16.17 | $-2.45 |
Financial Statements Comparison: Qiagen N.V vs Guardant Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | QGEN | GH |
|---|---|---|
| Revenue/Sales | $533.54M | $203.47M |
| Cost of Goods Sold | $199.25M | $74.72M |
| Gross Profit | $334.29M | $128.75M |
| Research & Development | $47.75M | $88.52M |
| Operating Income (EBIT) | $135.97M | $-111.04M |
| EBITDA | $200.58M | $-83.84M |
| Pre-Tax Income | $126.82M | $-94.87M |
| Income Tax | $30.57M | $290,000 |
| Net Income (Profit) | $96.25M | $-95.16M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | QGEN | GH |
|---|---|---|
| Cash & Equivalents | $638.76M | $698.57M |
| Total Current Assets | $1.74B | $927.03M |
| Total Current Liabilities | $516.94M | $225.75M |
| Long-Term Debt | $1.35B | $1.28B |
| Total Shareholders Equity | $3.41B | $-250.79M |
| Retained Earnings | $2.50B | $-2.67B |
| Property, Plant & Equipment | N/A | $140.50M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | QGEN | GH |
|---|---|---|
| Operating Cash Flow | $190.30M | $-49.41M |
| Capital Expenditures | $-43.90M | $-4.46M |
| Free Cash Flow | $95.48M | $-67.15M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-45.01M |
Short Interest & Institutional Ownership Analysis
| Metric | QGEN | GH |
|---|---|---|
| Shares Short | 6.67M | 8.74M |
| Short Ratio | 4.93 | 3.67 |
| Short % of Float | 0.05% | 0.07% |
| Average Daily Volume (10 Day) | 1,123,284 | 2,782,030 |
| Average Daily Volume (90 Day) | 1,273,311 | 2,486,587 |
| Shares Outstanding | 216.12M | 123.99M |
| Float Shares | 214.89M | 119.85M |
| % Held by Insiders | 0.02% | 0.04% |
| % Held by Institutions | 0.89% | 0.99% |
Dividend Analysis & Yield Comparison: Qiagen N.V vs Guardant Health
| Metric | QGEN | GH |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.44 | N/A |
| 3-Year Avg Dividend Yield | 3.03% | N/A |
| 3-Year Total Dividends | $1.32 | N/A |
| Ex-Dividend Date | Jan 30, 2024 | N/A |